Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 3 papers. Top paper: “A multicenter, open-label phase Ib/II study of cadonilimab (anti PD-1 and CTLA-4 bispecific antibody) monotherapy in previously treated advanced non–small-cell lung cancer (AK104-202 study)”.
Yuxiang Ma, Yun Fan, Jianya Zhou, Nong Yang, Qitao Yu +8 more
Weifeng Song, Ting Zhou, Saurabh Aggarwal, Tamás Jilling, Stavros Garantziotis +2 more
Weifeng Song, Zhihong Yu, Shaoyan Zhang, Anoma Nellore, Charles W. Hoopes +3 more